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Preface
Fetal alcohol spectrum disorders (FASD) represent a range of physical, mental, and behavioral disabilities caused
by alcohol use during pregnancy, or prenatal alcohol exposure (PAE). FASDs are considered to be one of the
leading preventable causes of developmental disability, with an estimated 119,000 children being born with
FAS each year in the world (Popova et al. 2017).¹ Despite its high prevalence, FASD is often misdiagnosed or
underdiagnosed, making intervention more challenging. A multidisciplinary team of providers who understand the
diagnostic requirements is crucial for an accurate FASD diagnosis.
Since the 1700s, the physical and behavioral characteristics of children exposed to alcohol prenatally have been
reported. In 1972, Jones and Smith coined the term fetal alcohol syndrome to describe these findings in children
born to alcoholic mothers.² In 1996, the Institute of Medicine distinguished four different disorders resulting from
PAE: fetal alcohol syndrome (FAS), partial fetal alcohol syndrome (PFAS), alcohol-related neurodevelopmental
disorder (ARND), and alcohol-related birth defects (ARBD).³ Since then, the diagnostic criteria have been revised
multiple times, with different versions in use around the world (Canadian Guidelines, CDC, etc.).4,5,6 The diagnostic
criteria presented in this booklet are based on the Updated Clinical Guidelines for Fetal Alcohol Spectrum Disorders,
developed in the United States, with the exception that 10 grams of alcohol is used instead of 14 grams as a
standard drink equivalent per WHO guidelines and the use of WHO growth charts for all ages instead of CDC growth
charts for children over 2 years.7 Further work is currently being done to come to a consensus on international
standards for FASD diagnosis, and each country should adjust their criteria according to their population and
experience.
The information provided in this booklet was initially developed for use in Spanish-speaking countries of
the Americas and is intended to serve as a training workbook for providers of various disciplines to learn
about the fundamentals of diagnosing FASD and to apply them to several case scenarios. Target audiences
include physicians, psychologists, allied health professionals, social workers, and other providers that may
encounter individuals affected by FASD. It is ideally used as a supplement for in-person training by experts in the
fields of dysmorphology, epidemiology, and neuropsychology.
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FASD diagnosis
Fetal alcohol spectrum disorders (FASD) represent a continuum of characteristics found in individuals who have
been prenatally exposed to alcohol.
The spectrum is comprised of four defined diagnostic categories: fetal alcohol syndrome (FAS), partial fetal
alcohol syndrome (PFAS), alcohol-related neurodevelopmental disorder (ARND), and alcohol-related birth defects
(ARBD).
There are five characteristics that are assessed in an FASD evaluation. The specific FASD diagnostic
categories differ according to the characteristics that are present.
1. Alcohol exposure. Information about prenatal alcohol exposure should be obtained from the biological
mother or other reliable collateral sources (e.g., family member, social service agency, medical record). FAS
and PFAS can be diagnosed without confirmation of prenatal alcohol exposure if sufficient characteristics are
present.
2. Facial features. This is defined as the presence of at least two of the three cardinal facial features: short
palpebral fissures (≤10th percentile), smooth philtrum, and thin vermilion border of the upper lip (the latter two
being ranked 4 or 5 on a racially normed lip/philtrum guide, as seen in Figure 4).8, 9, 10
3. Growth anomalies. These are defined as low height and/or weight (≤10th percentile). Population-specific
growth curves should be used for comparison. If unavailable, WHO growth charts are recommended for all
children.11, 12
4. Central nervous system (CNS) anomalies. These are defined as one or more of the following: small head
circumference (≤10th percentile), structural brain anomalies, or recurrent nonfebrile seizures.13
5. Neurobehavioral impairment. The amount of evidence needed for the neurobehavioral impairment
criterion differs for FAS and PFAS versus ARND. For children under 3, criteria for FAS or PFAS can be met if
developmental delays are greater than 1.5 standard deviations below average. ARND cannot be diagnosed
until 3 years of age. See pages 21-22 for full descriptions and guide.
The characteristics seen in FASD are not unique, as these are individually present in a variety of other genetic,
teratogenic, and neurodevelopmental conditions (such as autism spectrum disorder or intellectual disability).
However, the pattern of characteristics seen in alcohol exposure is specific to FASD. Therefore, FASD is a
diagnosis of exclusion, having first ruled out any other condition that would better explain the features seen in
an individual. Additional features of the face, joints, and hands are seen in FASD and can be helpful as supportive
evidence for a diagnosis. However, consultation with a clinical geneticist or the use of genetic testing may be
necessary in complex cases that do not clearly fit with an FASD diagnosis.
The level of the exposure including dose and timing during pregnancy, nutritional status and genetic factors
affecting the metabolism of alcohol can result in different phenotypes within the FASD continuum. Higher levels of
alcohol intake early in pregnancy (such as heavy drinking, defined as when a person drinks more than 60 grams
of pure alcohol in a single occasion) increase the risk for facial anomalies and birth defects. Repeated low-level
alcohol exposure (drinking regularly during pregnancy in lower amounts, below 60 grams in any occasion, for
example) can also result in an FASD phenotype, and exposure later in pregnancy is more likely to affect growth
and CNS development.
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FASD can present at any age. Newborns and infants may present for evaluation due to known prenatal alcohol
exposure. Some young children may be referred for evaluation due to facial dysmorphology and/or growth
deficiency. School-age children may present due to learning issues or behavioral problems at home or in the
classroom, particularly if physical features are absent. Occasionally, individuals will not be suspected until
adolescence due to behavioral problems or other evidence of disruption in higher executive function. Early
childhood (3-10 years) is the ideal age for FASD assessment. Facial features are indistinct in newborns and
infants and tend to fade during late adolescence. In addition, children within this age range can complete
neuropsychological tests across multiple domains of functioning to aid in rendering a diagnosis and intervention
planning.
The tools required for a diagnosis of FASD are a ruler, a tape measure, a scale, a racially-normed lip/philtrum
guide (Figure 4), appropriate growth charts (Figures 5-18), and a neuropsychological evaluation.

DIAGNOSTIC CRITERIA (Figure 1):
I.

Fetal alcohol syndrome (FAS) requires the first four characteristics of the spectrum, regardless of confirmed
maternal alcohol use: facial features, growth anomalies, CNS anomalies, and neurobehavioral impairment.
Neurobehavioral impairment can be met with a deficit defined as 1.5 SD below the mean in any of the
following:
a. Cognition (for children ≥ 3 years of age) which may be:
1. Global (general conceptual ability, or performance IQ, or spatial IQ) OR
2. One neurobehavioral domain (executive functioning, specific learning impairment, memory
impairment, or visual-spatial impairment).
b. Behavior with normal cognition in at least one domain for children ≥ 3 years of age (mood or behavioral
regulation impairment, attention deficit, or impulse control).
c.

Developmental delay (for children < 3 years of age).

II. Partial fetal alcohol syndrome (PFAS) diagnosis varies depending on whether alcohol exposure has been
confirmed or not.
a. If alcohol exposure is confirmed, only two criteria are required: facial features and neurobehavioral
impairment (as defined above for FAS).
b. If alcohol exposure is not confirmed, three criteria are required: facial features, neurobehavioral
impairment (as defined above for FAS), and growth anomalies OR CNS anomalies.
III. Alcohol-related neurodevelopmental disorder (ARND) requires confirmation of prenatal alcohol exposure
and neurobehavioral impairment. Neurobehavioral impairment can be met with deficits defined as 1.5 SD
below the mean in any of the following:
a. Cognition (for children ≥ 3 years of age) which may be:
1. Global (general conceptual ability, or performance IQ, or spatial IQ) OR
2. Two neurobehavioral domains (executive functioning, specific learning impairment, memory
impairment, or visual-spatial impairment).
b. Behavior with normal cognition in at least two domains for children ≥ 3 years of age (mood or behavioral
regulation impairment, attention deficit, or impulse control).
Note: Children under the age of 3 cannot be adequately assessed for ARND since a comprehensive
neurobehavioral assessment is required. Developmental delay alone is not sufficient to make this diagnosis
as it is common, non-specific, and may be temporary. Exposed children should be monitored and reevaluated after the age of 3 years to determine if they are affected.
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IV. Alcohol-related birth defects (ARBD) requires confirmation of prenatal alcohol exposure and one or more
major malformations (e.g., defects of cardiac, skeletal, renal, eye, and ear systems) that have been previously
associated with alcohol exposure. No criteria in the neuropsychological assessment need to be met. The
malformations seen in this diagnosis are related to the timing of exposure coinciding with critical periods of
embryogenesis. A comprehensive list of associated malformations can be found in the Hoyme (2016) article.

Figure 1. FASD Diagnostic Criteria Chart
This chart is a simplified visual aid that graphically demonstrates the FASD diagnostic criteria.

FETAL ALCOHOL SPECTRUM DISORDERS (FASD) DIAGNOSTIC CRITERIA
Abnormal
neuropsychology

Facial features

Low height and/or
weight

CNS anomalies

Major
malformation

WITH
DOCUMENTED(FASD)
ALCOHOL
EXPOSURE
L SPECTRUM
DISORDERS
DIAGNOSTIC
CRITERIA

Major
FAS
+
+
+
+
CNS anomalies
malformation
PFAS
+
COHOL EXPOSURE +
FAS ARND
+
++ *
+PFAS ARBD
+
+
WITHOUT
ARND
- DOCUMENTED -ALCOHOL EXPOSURE
FAS
++++
ARBD+
PFAS
+
+
+  or  +
D ALCOHOL EXPOSURE
in individuals under 3 years of age.
* Abnormal
FAS
+
+ neuropsychology+ in ARND cannot be-adequately assessed
PFAS
+
+  or  +
-

l features

Low height and/or
weight

gy in ARND cannot be adequately assessed in individuals under 3 years of age.
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Prenatal alcohol exposure
Assessing prenatal alcohol exposure (PAE) is important to the FASD diagnosis as the diagnostic process is highly
dependent on the confirmation of documented alcohol exposure. This section covers the definition of prenatal
alcohol exposure and a standard drink equivalent along with the methodology used to calculate standard drink
equivalents. Two methods are included for assessing this, the AUDIT and the AUDIT-C.

Definition of prenatal alcohol exposure
Prenatal alcohol exposure defined by the criteria are met with any one of the following:
•

Six or more standard drinks per week for two or more weeks

•

Three or more standard drinks per occasion on two or more occasions

•

Documentation of alcohol-related social or legal problems in proximity to the pregnancy (including the
three-month period prior to recognition of the pregnancy) such as:

•

•

--

History of driving while intoxicated

--

Treatment of an alcohol-related condition

--

Documentation of intoxication during pregnancy by blood, breath, or urine alcohol testing

Positive testing with established alcohol-exposure biomarker in maternal hair, fingernails, urine, blood,
placenta, or meconium such as:
--

Fatty acid ethyl esters

--

Phosphatidylethanol

--

Ethyl glucuronide

Increased prenatal risk associated with drinking during pregnancy assessed by a validated screening tool
such as:
--

AUDIT (Alcohol Use Disorders Identification Test): designed to screen for overall alcohol dependence with
scores of 20 or above requiring further diagnostic evaluation

--

AUDIT-C: abbreviated version of the AUDIT focusing on the first three questions regarding consumption
with a score of 5 or more indicating an increased risk for FASD

--

T-ACE: four question screening tool with a score of 2 or more indicating potential prenatal risk

--

Timeline Followback Method (TLFB)
--

Source: Sobell LC, Sobell M (1996): Timeline Followback Method (Drugs, Cigarettes, and Marijuana)
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Definition of a standard drink
A standard drink, as defined by the World Health Organization (WHO), is a drink with approximately 10 grams of
pure alcohol. Note that the Hoyme (2016) guidelines utilize 14 grams of pure ethanol to define a standard drink
equivalent. However, this booklet will defer to the WHO recommendation in order to enhance identification of
cases at risk.
It is important to note the type of alcoholic beverage consumed, as the amount of pure alcohol in a drink depends
on its alcohol content and its volume. The amount of liquid in an alcoholic drink, glass, can, or bottle is not
necessarily equivalent to the amount of alcohol (or ethanol) it contains. Different types of beer, wine, or malt liquor
can have varying amounts of alcohol content. For example, regular beers have about 5% alcohol content by
volume, ciders have about 5.5%, wines have about 12%, fortified wines about 20%, and spirits (whisky, vodka,
rum) have about 40% alcohol content. Therefore, one standard drink, measured in volume or weight, allows for
a comparison between beverages and totaling the alcohol consumed when various types of alcohol are taken.
Figure 2 uses the definition of one standard drink as 10 grams of alcohol to present various beverages with their
corresponding equivalent in number of standard drinks. For example, one can of beer will have 1.3 standard drinks,
while one 750-mL bottle of wine will have 7 standard drinks, and one 750-mL bottle of whisky will have 24 standard
drinks. A person drinking two cans of beer, one glass of “restaurant pour” wine, and one glass of fortified wine in
a meal, will have consumed 5.3 standard drinks. The volume of pure alcohol can be converted into grams of pure
alcohol by multiplying the amount of alcohol in milliliters (mL) by 0.79, the specific density of alcohol (Figure 3).

Figure 2. Standard drink approximations

What is a standard drink?
1 standard drink

=

BEER

WINE

5% Alcohol Content

12% Alcohol Content

10 grams
of pure alcohol
Volume of pure alcohol varies by
type of beverage with possible
variations based on locality.

Can
330 mL

Bottle
355 mL

Liter
1000 mL

100 mL

Glass

Restaurant Pour

180 mL

750 mL

1.3

1.4

4

1

1.7

7

FORTIFIED WINE

CIDER

SPIRITS

20% Alcohol Content

5.5% Alcohol Content

40% Alcohol Content

Bottle

Glass
60 mL

Half Bottle
375 mL

Bottle
750 mL

Bottle
330 mL

Half Liter
500 mL

Liter
1000 mL

Shot
44 mL

Bottle
750 mL

Liter
1000 mL

1

6

12

1.4

2.2

4.4

1.4

24

32
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Calculating a standard drink equivalent
In order to calculate a standard drink equivalent, two variables must be known: the alcohol percentage of a
beverage, and its volume. The formula in Figure 3 can be used to calculate a standard drink equivalent using
these two variables.

Figure 3. Standard drink equivalent calculation

Standard Drink Equivalent
S.D.E. =
Volume of beverage consumed (mL) X

% alcohol by volume

100%

X 0.79 grams pure alcohol/mL

10 grams

For example, a 100 mL glass of wine with 12% alcohol by volume:
100 mL X

12% alcohol by volume
100%

X 0.79 grams pure alcohol/mL

10 grams

= 0.95 standard drinks ≈ 1 standard drink

AUDIT/AUDIT-C
The Alcohol Use Disorders Identification Test (AUDIT) is a screening method developed by the WHO to identify
excessive drinking patterns or alcohol use disorders in a cross-national population.14 The test is comprised of ten
questions. The first three questions assess alcohol consumption, questions 4-6 refer to specific behaviors related
to alcohol dependence, and the last four questions inquire about consequences or problems related to alcohol
consumption. The test can be administered as an oral interview or as a self-report questionnaire. The patient must
respond to the first eight questions by assigning a score of 0-4, and a score of 0, 2, or 4 for the last two questions.
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AUDIT: Self-Report Version
PATIENT: Because alcohol use can affect your health and can interfere with certain medications and treatments,
it is important that we ask some questions about your use of alcohol. Your answers will remain confidential so
please be honest. Place an X in one box that best describes your answer to each question.

Questions

0

1

2

3

4

1. How often do you have a drink
containing alcohol?

Never

Monthly or
less

2-4 times a
month

2-3 times a
week

4 or more
times a week

2. How many drinks containing
alcohol do you have on a typical
day when you are drinking?

1 or 2

3 or 4

5 or 6

7 to 9

10 or more

3. How often do you have six or
more drinks on one occasion?

Never

Less than
monthly

Monthly

Weekly

Daily or almost
daily

4. How often during the last year
have you found that you were not
able to stop drinking once you had
started?

Never

Less than
monthly

Monthly

Weekly

Daily or almost
daily

5. How often during the last year
have you failed to do what was
normally expected of you because
of drinking?

Never

Less than
monthly

Monthly

Weekly

Daily or almost
daily

6. How often during the last year
have you needed a first drink in
the morning to get yourself going
after a heavy drinking session?

Never

Less than
monthly

Monthly

Weekly

Daily or almost
daily

7. How often during the last year
have you had a feeling of guilt or
remorse after drinking?

Never

Less than
monthly

Monthly

Weekly

Daily or almost
daily

8. How often during the last year
have you been unable to remember what happened the night
before because of your drinking?

Never

Less than
monthly

Monthly

Weekly

Daily or almost
daily

9. Have you or someone else
been injured because of your
drinking?

No

Yes, but not in
the last year

Yes, during the
last year

10. Has a relative, friend, doctor,
or other health care worker been
concerned about your drinking or
suggested you cut down?

No

Yes, but not in
the last year

Yes, during the
last year

Score

Total
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There have been multiple scoring systems developed for the AUDIT dependent on the population being screened
and the goals of the screening program. It has been noted that scores above 7 are indicative of harmful levels of
alcohol use and possible dependence. Scores of 10 or greater may reduce the false negative rate, but may cause
a reduction in the identification of at-risk individuals. Any program seeking to use the AUDIT should develop a
scoring system that is relevant and applicable for the population being targeted.
A modified version of the AUDIT, the AUDIT-C, has been developed in order to screen for prenatal alcohol
exposure. The AUDIT-C is comprised of the first three questions in the AUDIT and is meant to assess drinking
patterns during pregnancy and three months prior to the recognition of the pregnancy.

Questions

0

1

2

3

4

1. How often do you have a drink
containing alcohol?

Never

Monthly or
less

2-4 times a
month

2-3 times a
week

4 or more
times a week

2. How many drinks containing
alcohol do you have on a typical
day when you are drinking?

1 or 2

3 or 4

5 or 6

7 to 9

10 or more

3. How often do you have six or
more drinks on one occasion?

Never

Less than
monthly

Monthly

Weekly

Daily or almost
daily

Score

Total

To score the AUDIT-C, each individual score for each question must be added to obtain a total score.
•

A total score of 0 indicates no prenatal alcohol exposure

•

A total score of 1-4 confirms prenatal alcohol exposure

•

A total score of 5 confirms prenatal alcohol exposure, with high risk for FASD
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Figure 4. Lip/philtrum guides

Caucasian
Philtrum/Vermilion Scale

South African Mixed Race Lip/Philtrum Scale

5

4

5

4

3

3

2

2

1

Hoyme, HE, Hoyme, DB, Elliott, AJ, et al. 2015. A South African
mixed race lip/philtrum guide for diagnosis of fetal alcohol
spectrum disorders. Am J Med Genet Part A. 167A:752-5.
Reproduced with permission from John Wiley and Sons.

1

Lip/philtrum guide for the white population, incorporating
a 45-degree view. This guide was produced by analysis
of photographs of >800 white children from school-based
studies in the United States. Scores are assessed
separately for the philtrum and vermilion border, scores
of 4 or 5 are compatible with FAS or PFAS. Reproduced
with permission from the Journal of Pediatrics, Vol. 138,
Page 8, Copyright © 2016 by the AAP.

9

Palpebral fissure length
The palpebral fissure length is typically determined using a ruler to measure the distance between the inner
canthi (where the eyelids meet interiorly) and the outer canthi (where the eyelids meet laterally). The ruler
should be brought as close as possible to the eye without touching the eyelashes as shown in image A, and the
examiner should be seated at the same level as the subject to avoid parallax error. The ruler should follow the
natural slant of the eye and the subject should be asked to look up in order to make both inner and outer canthi
visible as shown in image B. Image C explains why using a photographic image decreases the accuracy of the
measurement, as the measurement obtained is “A”, while the correct measurement is “C.” A percentile graph for
palpebral fissure length is provided in Figure 5 and measurements that fall at or below the 10th percentile are
considered short.

Figure 5. Palpebral fissure length
PALPEBRAL FISSURE LENGTH

Source: Thomas IT, Gaitantzis YA, Frias JL. Palpebral fissure length from 29 weeks gestation to 14 years. J Pediatr. 1987
Aug;111(2):267-8. Permission to reprint was granted by the Canadian Copyright Licensing Agency.
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Growth curves
Population-specific growth charts should be used in order to determine the weight and height percentile of an
individual. If unavailable, WHO growth charts are recommended and are provided below for most instances.
Due to the absence of a weight-for-age growth chart for children over the age of 10 years, CDC growth charts
are provided for this population. When birth weight or birth length are being assessed in premature infants, it is
recommended to use the International Fetal and Newborn Growth Consortium for the 21st Century (Intergrowth21st) charts available at https://intergrowth21.tghn.org/

Weight
Figure 6. Weight for boys ages 0–5 years
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Figure 7. Weight for girls ages 0–5 years
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Figure 8. Weight for boys ages 5–10 years

Figure 9. Weight for girls ages 5–10 years
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Length
Figure 10. Length for boys ages 0–5 years
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Figure 11. Length for girls ages 0–5 years
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Figure 12. Height for boys ages 5–19 years

Figure 13. Height for girls ages 5–19 years

Permission to reprint weight and height charts was granted by the WHO.
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Weight and height
Figure 14. Weight and height for boys ages 2–20 years
2 to 20 years: Boys
Stature-for-age and Weight-for-age percentiles
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SOURCE: Developed by the National Center for Health Statistics in collaboration with
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http://www.cdc.gov/growthcharts
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Figure 15. Weight and height for girls ages 2–20 years
2 to 20 years: Girls
Stature-for-age and Weight-for-age percentiles
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Permission to reprint was granted by the CDC.
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Head circumference
To measure the head circumference of a child, a measuring tape that cannot be stretched must be used. Place
the tape around the widest possible circumference of the head, which is on the broadest part of the forehead
above the eyebrows, above the ears, and on the most prominent part of the back of the head (CDC). Populationspecific head circumference charts should be used in order to determine the head circumference percentile of an
individual. If unavailable, WHO growth charts are recommended and are provided below for most instances. Due
to the absence of a head circumference-for-age growth chart for individuals over the age of 5 years, additional
head circumference charts are provided for this population (Rollins, Collins, and Holden, 2010).13

Figure 16. Head circumference for boys 0–5 years
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Figure 17. Head circumference for girls 0–5 years
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Permission to reprint head circumference charts was granted by
the WHO.
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Figure 18. Head circumference for boys and girls 0–21 years

Source: Rollins JD, Collins JS, Holden KR. United States head circumference growth reference charts: birth to 21 years. J Pediatr.
2010 Jun;156(6):907-913.e2. Permission to reprint was granted by Elsevier.
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Dysmorphology checklist
The three cardinal facial features (short palpebral fissures, smooth philtrum, and thin vermilion border of the upper
lip) are essential elements of the diagnostic criteria. However, there are several other physical features that have
been observed in FASD, which are medically inconsequential but can be subtle cues of an underlying diagnosis.
These features are termed minor anomalies, to distinguish them from major anomalies that are birth defects
of significant medical consequence. Minor anomalies in isolation do not individually represent the presence or
absence of a condition and can be seen in the general population with some frequency. However, some minor
anomalies are enriched in the FASD population. These anomalies are more common in patients with FAS and
PFAS, but have also been noted occasionally in individuals with ARND. The checklist below provides a systematic
method to document the primary features of FASD along with some of the minor anomalies that have been
observed in FASD cases. It can be used both in clinical and research settings.
FASD Evaluation Worksheet
Dysmorphology Checklist

Gender: ☐ Male

☐ Female

Patient name:
Examiner:
Examination site:
Date of exam:

Day

Month

Year

Date of birth:

Day

Month

Year

Current age:

Years

Months

Height (cm)
Weight (kg)

.
.

Percentile:

≤ 10%

Significant?

Yes ☐ No ☐

Percentile:

≤ 10%

Significant?

Yes ☐ No ☐

Head circumference (cm)

.

Percentile:

≤ 10%

Significant?

Yes ☐ No ☐

Inner canthal distance (cm)

.

Percentile:

≤ 25%

Significant?

Yes ☐ No ☐

Percentile:

≤ 25%

Significant?

Yes ☐ No ☐

Percentile:

≤ 25%

Significant?

Yes ☐ No ☐

Interpupillary distance (cm)

.

Palpebral fissure-Left/Right (cm)
Outer canthal distance (cm)
Face:

.

/

.

.

Percentile:

Midface hypoplasia

Yes ☐ No ☐

Ears: Cupped/low-set/railroad track ears

Yes ☐ No ☐

Ears:
Strabismus
Ptosis
Epicanthal folds

Yes ☐ No ☐
Yes ☐ No ☐
Yes ☐ No ☐

Unilateral/Bilateral
Unilateral/Bilateral
Unilateral/Bilateral

Nose:
Flat nasal bridge
Anteverted nose
Philtrum lipometer code:
Lip lipometer code:

Yes ☐ No ☐
Yes ☐ No ☐
1 2 3 4 5
1 2 3 4 5

Yes ☐ No ☐
Yes ☐ No ☐
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Mouth:
Prognathism
General:
Hypoplastic nails
5th finger clinodactyly
Camptodactyly
Creases:
Hockey stick crease
Single transverse crease
Hypoplastic thenar crease

Yes ☐
Unilateral/Bilateral
Unilateral/Bilateral
Unilateral/Bilateral
Unilateral/Bilateral
Unilateral/Bilateral
Unilateral/Bilateral

Yes
Yes
Yes
Yes

☐
☐
☐
☐

No ☐
No
No
No
No

☐
☐
☐
☐

Arms:
Decreased pronation/supination

Yes ☐

No ☐

Heart:
Atrial septal defect
Ventricular septal defect
Other heart defect

Yes ☐
Yes ☐
Yes ☐

No ☐
No ☐
No ☐

Additional notes:
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Neuropsychology
The direct effects of alcohol on the developing forebrain lead to a specific constellation of neurobehavioral
impairments in children with FASD.15 In order to assess the degree of neurologic impact from PAE, a
comprehensive neuropsychological assessment evaluating the following three domains should be performed:
1. Global intellectual ability (full-scale IQ, verbal IQ, performance IQ, or spatial IQ)
2. Cognition (executive functioning, learning, memory, and visual-spatial skills)
3. Behavior and self-regulation (mood, behavioral regulation, attention, and impulse control)
Based on the Hoyme (2016) criteria, impairment is defined as 1.5 standard deviations (SD) from the mean. Table
1 lists types of scores commonly reported for neuropsychological assessments.

Table 1. Scores commonly reported for neuropsychological assessments
Type of score

Mean

SD

Examples

Standard Score (SS)

100

15

WISC-IV Index scores, ENI-2 Composite scores

Scaled Score (Sc)

10

3

WISC-IV Subtest scores, ENI-2 Subtests

T-Scores (T)

50

10

Measures of behavior (e.g., SENA)

When assessing cognition, impairment is defined as a deficit of 1.5 SD below the mean, which is equivalent to
less than the 7th percentile. Conversely, when assessing behavior, impairment is defined as a score that is 1.5
SD above the mean, which is equivalent to greater than the 93rd percentile. The image below demonstrates this
graphically.
For cognitive scores where low scores reflect
poorer performance or weaker skills:

For behavioral scores where high scores reflect
more problems:
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The neurobehavioral impairment required for an FAS or PFAS diagnosis in children older than 3 years of age
is defined as a deficit of 1.5 SD below the mean in global intellectual ability OR one cognitive domain. The
neurobehavioral impairment can also be met with a deficit of 1.5 SD below the mean in at least one behavioral
and self-regulation domain.
Due to the lack of physical findings, the neurobehavioral impairment required for an ARND diagnosis is more
stringent. In ARND, it is defined as a deficit of 1.5 SD below the mean in global intellectual ability OR two
cognitive domains. The neurobehavioral impairment for this diagnostic category can also be met with a deficit of
1.5 SD below the mean in at least two behavioral and self-regulation domains.
For children younger than 3, developmental delay is sufficient to meet the neurobehavioral impairment criteria for
an FAS or PFAS diagnosis, but not for the diagnosis of ARND. This is because developmental delay is common,
non-specific, and may be temporary.
Based on the authors’ previous experience conducting trainings in Latin American countries, a battery
of neuropsychological tests that assess for all three neurobehavioral domains is listed below. The
neuropsychological assessment battery should be adjusted based on the individual child’s abilities and needs,
referral question, or clinician judgment. When available, neuropsychological assessments normed for a
comparable population should be used.
Selected Assessment Instruments:
1. Global Impairment: Weschler Intelligence Scale for Children (WISC-IV)
2. Cognitive Impairment: Evaluación Neuropsicológica Infantil -2 (ENI-2)
3. Behavioral Impairment: Sistema de Evaluación de Niños y Adolescentes (SENA) - parent questionnaire

Table 2 lists the individual domains assessed in an FASD evaluation with the corresponding neuropsychological
test from the selected battery. Table 3 lists additional neuropsychological assessments in Spanish.
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Table 2. Individual domains assessed in an FASD evaluation
Test battery/
abbreviation

Where
normed

Age range

WISC-IV Spanish

USA, Mexico

Ages 6-16

ENI-2

Mexico,
Colombia

Ages 5-16

ENI-2

Mexico,
Colombia

Ages 5-16

WISC-IV Spanish

USA, Mexico

Ages 6-16

ENI-2

Mexico,
Colombia

Ages 5-16

• Reading (10 possible subtests to choose from)
• Writing (8 possible subtests to choose from)
• Arithmetic (10 possible subtests to choose from)

ENI-2

Mexico,
Colombia

Ages 5-16

Behavior
functioning

Sistema de Evaluación de Niños y Adolescentes

Questionnaire

Spain

Ages 3-18

Perceptual skills

Evaluación Neuropsicológica Infantil, 2nd Ed.
ENI-2

Mexico,
Colombia

Ages 5-16

Domain

General cognitive
ability

Tests/ subtests
Wechsler Intelligence Scale for Children
• Full Scale IQ (10 subtests)
• Verbal Comprehension Index (3 subtests)
• Perceptual Reasoning Index (3 subtests)
Evaluación Neuropsicológica Infantil, 2nd Ed.

Memory

•
•
•
•

Encoding – Verbal (2 subtests)
Encoding – Visual (1 subtest)
Recall – Verbal (4 subtests)
Recall – Visual (4 subtests)

Evaluación Neuropsicológica Infantil, 2nd Ed.

Executive
functioning

•
•
•
•

Verbal fluidity (3 subtests)
Graphical fluidity (2 subtests)
Cognitive flexibility (1 test, 3 main scores)
Planning and organizing (1 test, 4 main scores)

Wechsler Intelligence Scale for Children
• Working Memory Index (2 subtests)

Visual-spatial

Evaluación Neuropsicológica Infantil, 2nd Ed.
• Graphic abilities (3 subtests)
• Spatial abilities (5 subtests)

Evaluación Neuropsicológica Infantil, 2nd Ed.

Learning

(note: not part of FASD
diagnosis but included
as part of memory
delay in ENI)

• Tactile (2 subtests)
• Visual (5 subtests)
• Auditory (3 subtests)
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Table 3. Additional neuropsychological assessments in Spanish
Domain

Tests/ subtests

Test battery/
abbreviation

Where
normed

Age range

Development

Bayley Scales of Infant and Toddler Development (III)
Psychomotor Development Test

Bayley-3
TEPSI

USA

Ages 1-42
months
Ages 2-5

General
cognitive
ability

Differential Abilities Scale – 2 Early Years
British Ability Scales
Wechsler Preschool and Primary Scale of Intelligence
Wechsler Intelligence Scale for Children
Wechsler Abbreviated Scales of Intelligence
Wechsler Nonverbal Scale of Ability
Reynolds Intellectual Assessment Scales

DAS-II
BAS-II
WPPSI-III
WISC-IV Spanish
WASI-II
WNV
RIAS

USA
Spain
USA, Mexico
USA, Mexico
USA
USA
Spain

Ages 2.5-6
Ages 2.5-17
Ages 2.5-7.5
Ages 6-16
Ages 6-90
Ages 4-21
Ages 3-94

Verbal
memory

Recall of Digits Forward
Sentence Repetition
Narrative Memory
List Memory / Delayed
Test of Memory and Learning

DAS-II
NEPSY-II
NEPSY-II
NEPSY-II
TOMAL

USA
USA
USA
USA
Spain

Ages 2.5-17
Ages 3-6
Ages 3-16
Ages 7-12
Ages 5-19

Non-verbal
memory

Recognition of Pictures
Recall of Objects
Memory for Faces / Delayed
Memory for Designs / Delayed
Test of Memory and Learning
Rey Complex Figure Test

DAS-II
DAS-II
NEPSY-II
NEPSY-II
TOMAL
REY

USA
USA
USA
USA
Spain
Spain

Ages 2.5-17
Ages 4-17
Ages 5-16
Ages 3-16
Ages 5-19
Ages 4-15

Working
memory

DAS-II/BAS-II Working Memory Composite
WISC-IV Working Memory Index
Word List Interference

DAS-II, BAS-II
WISC-IV
NEPSY-II

USA, Spain
USA, Mexico
USA

Ages 3.5-17
Ages 6-16
Ages 7-16

Executive
functioning

Auditory Attention & Response Set
Inhibition
Animal Sorting
Word Generation
Design Fluency
Batería Neuropsicológica de Funciones Ejecutivas y
Lóbulos Frontales
Evaluación Neuropsicológica de las Funciones
Ejecutivas en Niños
STROOP Color and Word Test
Wisconsin Card Sorting Test
Behavior Rating Inventory for Executive Functioning

NEPSY-II
NEPSY-II
NEPSY-II
NEPSY-II
NEPSY-II
BANFE
ENFEN
STROOP
WCST
Questionnaire

USA
USA
USA
USA
USA
Mexico
Spain
Spain
Spain
USA, Spain

Ages 5-16
Ages 5-16
Ages 7-16
Ages 3-16
Ages 5-12
Ages 6-80
Ages 6-12
Ages 7-80
Ages 6-89
Ages 2.5-5,
5-18

Visual-spatial

Arrows
Geometric Puzzles
Design Copying
Developmental test of Visual Motor Integration
Frosting Developmental Test of Visual Perception
Rey Complex Figure Test

NEPSY-II
NEPSY-II
NEPSY-II
VMI
DTVP-3
REY

USA
USA
USA
USA
Mexico
Spain

Ages 5-16
Ages 3-16
Ages 3-16
Ages 2-99
Ages 4-12
Ages 4-15

Attention &
information
processing

Auditory Attention & Response Set
Children Sustained Attention Task - Revised

NEPSY-II
CSAT-R
WISC-IV, WPPSI

USA
Spain
USA, Mexico

Ages 5-16
Ages 6-11
Ages 4-16

Behavior
functioning

Child Behavior Checklist
Behavior Assessment System for Children
Sistema de Evaluación de Niños y Adolescentes

Questionnaire
Questionnaire
Questionnaire

USA
USA, Spain
Spain

Ages 1.5-5,
6-18
Ages 2-5,
6-11, 12-21
Ages 3-18

General rules for the administration of neuropsychological testing in young children
General Introduction to Testing
•

Build rapport with the child; younger children may need more time to be comfortable or separate from parents.
Briefly describe the type of tasks: looking at pictures, answering questions, working with blocks.
--

Avoid “playing games.”

•

Mention some things will be easy and some will be harder.

•

You can say we don’t expect you to know how to do all of them, just try your best.

•

Tell them you can take a break or go to the bathroom if needed.

•

Ask if they have any questions.

General Tips on Managing Effort & Behavior
•

Praise effort throughout testing and when the child needs encouragement; avoid giving the child any
indication of right/wrong unless instructions say to (e.g., nodding, “ok,” “good”)
--

“You’re working hard!” “Way to work.”

--

“I like how you are thinking so hard about these.”

•

Be fun and engaging.

•

Try to avoid too much conversation between subtests. Moving smoothly from one test to the next will help
keep time to a minimum and the child on task.

•

Avoid having any unnecessary materials on the table.

•

If the child is getting very frustrated or refusing to come to the table, try offering some choices (e.g., walk to
the table like a penguin or elephant, choose which pencil to use, take a break now or after the next subtest,
turn the pages) – praise heavily if they make an appropriate choice.

•

Use statements instead of questions when you want the child to do something.

•

Take breaks when needed. Avoid a break in the middle of a subtest unless it is absolutely necessary.

•

Do not have the child eat during testing as the materials may get dirty or it may interfere with their
performance. Encourage to have a snack during breaks.

•

Materials are very expensive and hard to replace. Do not let children mistreat materials (e.g., bend cards,
mess with bindings)

•

Never force the child to continue if they protest. Going to talk to a parent can help.

•

Sticker charts or count downs can be useful for keeping the child engaged.
--

•

Note that these may need to be prepared in advance.

You may offer children a small prize for completing the assessment. This may be a useful incentive for getting
them to continue participating. Use judgment when employing this strategy.

KEY POINT: You must try to be as precise as possible. Say the words exactly as written without adding anything
extra or skipping any words. Pay close attention to what you should be pointing to and how the materials should
be placed. This all is necessary for the resulting scores to be valid. Everything should be the same for all kids, just
as was done when the test was created and normed.
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Case examples
Prenatal alcohol exposure
Case 1
A 12-year-old male, Genaro, is having difficulty in school with memory retention, inattention, and hyperactivity. He
is accompanied to clinic by his mother and paternal grandmother. When the pregnancy history is reviewed, the
mother reports not drinking at all during her pregnancy. However, the paternal grandmother states that the mother
is a “habitual drinker,” often having multiple glasses of wine daily. The mother responds that she usually has
some wine with dinner 2-3 times per week, but remains adamant that she did not drink during her pregnancy with
Genaro.
Growth parameters for Genaro (height, weight, and head circumference) are normal. Physical examination shows
a hockeystick crease on the right hand, and railroad tracking on the right ear. Palpebral fissure length is at the
12th percentile. Lip is a grade 4 and philtrum is a grade 3.
Neuropsychologic assessment reveals >1.5 standard deviation reduction in one domain that assesses memory
impairment. The remainder of the assessment is normal.
1. Based on the information presented, can prenatal alcohol exposure be confirmed for Genaro?
2. Which FASD diagnostic categories should be considered for Genaro? Which ones can be excluded?
3. What additional information might be helpful in assessing Genaro?
4. What are some ways that the situation can be handled so that the environment is more conducive to elicit
necessary information?
Case 2
A 21-year-old pregnant woman, Luisa, comes to clinic for her first prenatal visit. She found out she was pregnant
one week ago by using an at-home pregnancy test. She is concerned because she was at a party three weeks
ago and consumed six mixed drinks. When further questioned, she stated she was not sure of the amount of
liquor in the drinks, but that it was predominantly rum mixed with cola. The first day of her last menstrual cycle
was five weeks ago. Medical evaluation demonstrates a pregnancy at six weeks gestation.
1. Does the level of drinking in this case meet the threshold for prenatal alcohol exposure?
2. How would you counsel the patient regarding the risk to the embryo in this scenario?
3. If the event was repeated in the first trimester, how would the risk change?
4. If the event was repeated in the second trimester, how would the risk change?
Case 3
A 33-year-old pregnant female, Sofia, presents for a routine prenatal visit at 20 weeks gestation. During her visit,
Sofia reports that she drinks once a week. When she drinks, she normally has about five beers. She drank seven
beers at a party six months ago, but that happened only once in the past year. She never has difficulty stopping
once started and has not had any issues with going to her job. After a night of heavy drinking, she feels that a cup
of coffee in the morning is sufficient to start her day. She has no guilt about her drinking, but reported one episode
in the past year when she couldn’t remember what happened during a night of drinking. She has never been
injured and no one in her social circle has ever expressed concern about her drinking.
1. What tool could be used to assess the risk level of her drinking? What other piece of information is necessary
in assessing a more accurate risk?
2. Does the case scenario meet the criteria for prenatal alcohol exposure?
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3. What findings on an ultrasound from today’s visit would be suspicious for an FASD?
4. If the ultrasound was normal, what findings might still be present but missed by ultrasound?
5. How would you counsel this patient regarding the future? What plan would you put in place for appropriate
surveillance?
Case 4
A 3-year-old female, Maria, is brought in for evaluation for possible FASD. She is accompanied by a foster parent
who has limited knowledge regarding the biological mother of Maria or the pregnancy. She brings records that
state the following:
“Maria was removed from the home at age 2 years after it was witnessed that the mother and father were using
methamphetamine in her presence. Hair samples from Maria tested positive for the drug. Maria was then returned
to the parents’ care after a drug monitoring plan was put in place. At 2 years 3 months, during a home visit, a
case worker observed the biological mother giving Maria a bottle that was later determined to contain vodka. The
mother was tested and found to have a blood alcohol concentration of 0.385 mg/L. Maria was then removed for
the final time from the home. The biological mother entered a substance abuse program. Unfortunately, she failed
to complete the program and continues to abuse alcohol and methamphetamine.
“Medical records reveal that the biological mother had three other children, Juan, Jose, and Andrea. Juan
underwent cord blood testing at birth, which was positive for alcohol. Juan was removed from the care of the
mother due to the cord blood test. Jose and Andrea were later removed from the care of the mother due to
concerns of physical neglect and hair testing that was positive for marijuana and methamphetamine. The father of
the children died unexpectedly of unknown cause. Maria never underwent cord blood testing.”
Growth parameters for Maria (height, weight, and head circumference) are normal. Physical examination shows
no abnormalities. Palpebral fissure length is at the 25th percentile. Lip is a grade 3 and philtrum is a grade 2.
Questions:
1. Based on the information presented, can prenatal alcohol exposure be confirmed for Maria? Juan? Jose and
Andrea?
2. Which FASD diagnostic categories should be considered for Maria? Which ones can be excluded?
3. What additional information might be helpful in assessing Maria?
4. Which FASD diagnostic categories should be considered for Juan?
5. What additional information might be helpful in assessing Juan?
6. Are Jose and Andrea at risk for an FASD?

Answer key
Case 1
1. Based on the information presented, can prenatal alcohol exposure be confirmed for Genaro? No
2. Which FASD diagnostic categories should be considered for Genaro? ARND is a consideration, though
further information regarding the maternal drinking early in the pregnancy is necessary. A comprehensive
neuropsychological assessment must also be conducted.
Which ones can be excluded? FAS, PFAS, and ARBD are excluded based on the lack of physical findings.
3. What additional information might be helpful in assessing Genaro? Questions regarding maternal alcohol use in
the three months prior to the pregnancy and the period before she was aware that she was pregnant should be
asked.
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4. What are some ways that the situation can be handled so that the environment is more conducive to elicit
necessary information? Removing the grandparent from the room, building rapport with the patient, and
normalizing the behavior are important to ensuring trust and eliciting a positive response when the behavior is
seen as associated with stigma.
Case 2
1. Does the level of drinking in this case meet the threshold for prenatal alcohol exposure? No, because there is
only one episode of drinking reported.
2. How would you counsel the patient regarding the risk to the embryo in this scenario? This is the all-or-none
period of pregnancy, so one can reassure the patient but with caution that additional episodes may cause
harm.
3. If the event was repeated in the first trimester, how would the risk change? There would be sufficient exposure
to meet the threshold for the criteria. This is the embryonic period, so birth defects, stillbirth, growth deficiency,
neurobehavioral impairment, and facial features can occur with exposure at this time.
4. If the event was repeated in the second trimester, how would the risk change? After the embryonic phase, the
primary risks are for growth deficiency and neurobehavioral impairment.
Case 3
1. What tool could be used to assess the risk level of her drinking? The AUDIT-C can be used, since this
information contains all three components of the questionnaire.
What other piece of information is necessary in assessing a more accurate risk? Her definition of a “beer”
needs to be converted into a standard equivalent.
2. Does the case scenario meet the criteria for prenatal alcohol exposure? Yes, both as one can of beer (1 SDE
= AUDIT-C score of 5) and as one liter of beer (4 SDE = AUDIT-C score of 9).
3. What findings on an ultrasound from today’s visit would be suspicious for an FASD? Reduced growth
parameters (crown-rump length, estimated weight, head circumference).
4. If the ultrasound was normal, what findings might still be present but missed by ultrasound? Facial
dysmorphology and neurobehavioral impairment.
5. How would you counsel this patient regarding the future? What plan would you put in place for appropriate
surveillance? The amount of alcohol exposure to this infant is high. The greatest risk for physical findings is in
the second six weeks post-conception (gestational age 6-12 weeks). For example, for every one drink increase
in the average number of drinks consumed, there was a 25% increased risk for smooth philtrum, 22% increased
risk for thin upper lip, 12% increased risk for microcephaly, and 16% increased risk for reduced birth weight.
The pregnancy should be monitored for intrauterine growth deficiency and extensive counseling regarding
alcohol consumption should be provided. The newborn should be followed for any physical findings and a
neuropsychological assessment will be necessary at 3-5 years of age to assess for impairment.
Case 4
1. Based on the information presented, can prenatal alcohol exposure be confirmed for Maria? No
Juan? Yes
Jose and Andrea? No
2. Which FASD diagnostic categories should be considered for Maria? ARND would be a consideration if more
information can be obtained regarding prenatal alcohol exposure.
Which ones can be excluded? FAS, PFAS, and ARBD are excluded based on the lack of physical findings.
3. What additional information might be helpful in assessing Maria? If she can be located, an interview or tool
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such as the timeline follow-back method could be utilized. Additionally, collateral information can be used if
there is legal evidence of a DUI or a positive BAL during or in the three months leading up to the pregnancy.
4. Which FASD diagnostic categories should be considered for Juan? All of them.
5. What additional information might be helpful in assessing Juan? Growth parameters, facial dysmorphology,
and neuropsychology is necessary to determine if he has an FASD.
6. Are Jose and Andrea at risk for an FASD? Not based on the available information, though the historical
drinking pattern is concerning.

Comprehensive FASD evaluation
CASE #1 (Age 9yr-10mo girl)
Case #1 lives with her adoptive mother and older biological sister. She
was born at 27 weeks gestation. Prenatal exposure is confirmed for daily
alcohol and marijuana use throughout pregnancy. She was removed from
her biological mother at birth and spent three months in the Neonatal
Intensive Care Unit. She was in foster care until 7 months of age and then
went to live with her adoptive mother. She receives special education
services at school in a small classroom setting. She has been diagnosed
with ADHD and a mood disorder. She takes guanfacine and aripiprazole to
manage attention and behavioral symptoms.
Dysmorphology Exam: Height 139 cm, weight 34 kg, OFC 53 cm, palpebral fissure length 2.4 cm. Lip and
philtrum shown above. No history of seizures.
Selected Test Results:
Intellectual Functioning (WISC-IV)
Full Scale IQ Standard Score (SS) = 68, 2nd percentile
Academic Achievement (ENI-2)
Reading precision: words with errors in reading aloud Scaled Score (Sc) = 6, 13th percentile
Arithmetic: written calculus Sc = 3, 1st percentile
Writing precision: percent of words with errors in written recall Sc = 4, 2nd percentile
Verbal Memory (ENI-2)
Auditory-verbal memory SS = 60, <1st percentile
Auditory stimuli recall memory SS = 64, 1st percentile
Executive Functioning (ENI-2)
Cognitive flexibility: percentage of perseverative responses Sc = 3, 1st percentile
Planning and organizing: correct designs Sc = 4, 2nd percentile
Behavior Problems (SENA) (*high scores = worse performance)
Attention difficulties T = 77, >99th percentile
Hyperactivity and impulsivity T = 65, 94th percentile
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Present/absent

Criteria

Notes

A. Characteristic pattern of minor facial anomalies, including two or more of the following:
1. Short palpebral fissures
2. Thin vermilion border of the upper lip
3. Smooth philtrum
B. Growth deficiency
Height and/or weight less than or equal to 10th
percentile
C. Deficient brain growth, structural brain anomalies, or recurrent nonfebrile seizures
1. Head circumference < 10th percentile
2. Structural brain anomalies
3. Recurrent nonfebrile seizures
D. Neurobehavioral impairment (more than 1.5 standard deviations below the mean)
1. Global impairment (IQ)
2. Cognitive impairment: impairment in executive
functioning, specific learning impairment, memory,
or visual-spatial
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
3. Behavioral impairment: impairment in selfregulation as evidenced by mood or behavioral
regulation, attention deficit, or impulse control
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
E. Evidence of prenatal alcohol exposure
Confirmation of prenatal alcohol exposure
FINAL DIAGNOSIS:

30

CASE #2 (Age 7yr-7mo girl)
Case #2 lives with her biological mother. Her mother reports that she was in
college when she got pregnant with the child and was binge drinking a lot on the
weekends. She discovered she was pregnant when she was 3.5 months along.
Upon pregnancy recognition, she stopped drinking and sought prenatal care. The
child was diagnosed with ADHD at 5 years old and began medication to manage
her inattention and hyperactivity. However, she continues to struggle at home and
school with regulating her behavior. Although she tries hard, she gets in trouble a
lot at school, especially during unstructured times of the day.

Dysmorphology Exam: Height 113 cm, weight 26 kg, OFC 49 cm. Palpebral fissure length 2.4 cm. Lip and
philtrum shown above. No known history of seizures.
Selected Test Results:
Intellectual Functioning (WISC-IV)
Full Scale IQ SS = 106, 66th percentile
Academic Achievement (ENI-2)
Reading precision: words with errors in reading aloud Sc = 8, 25th percentile
Arithmetic: written calculus Sc = 8, 25th percentile
Writing precision: percent of words with errors in written recall Sc = 8, 25th percentile
Memory (ENI-2)
Auditory-verbal memory SS = 70, 2nd percentile
Auditory stimuli recall memory SS = 66, 1st percentile
Visual memory SS = 110, 75th percentile
Visual stimuli recall memory SS = 110, 75th percentile
Executive Functioning (Child testing; ENI-2)
Verbal fluidity SS = 100, 50th percentile
Planning and organizing: correct designs Sc = 4, 2nd percentile
Cognitive flexibility: percentage of perseverative responses Sc = 1, 1st percentile
Behavior Problems (SENA) (*high scores = worse performance)
Hyperactivity and impulsivity T = 68, 96th percentile
Attention difficulties T = 67, 96th percentile
Emotional regulation problems T = 71, 98th percentile
Index of problems in executive functioning T-score = 73, 99th percentile
Anxiety T = 55, 70th percentile
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Present/absent

Criteria

Notes

A. Characteristic pattern of minor facial anomalies, including two or more of the following:
1. Short palpebral fissures
2. Thin vermilion border of the upper lip
3. Smooth philtrum
B. Growth deficiency
Height and/or weight less than or equal to 10th
percentile
C. Deficient brain growth, structural brain anomalies, or recurrent nonfebrile seizures
1. Head circumference < 10th percentile
2. Structural brain anomalies
3. Recurrent nonfebrile seizures
D. Neurobehavioral Impairment (more than 1.5 standard deviations below the mean)
1. Global impairment (IQ)
2. Cognitive impairment: impairment in executive
functioning, specific learning impairment, memory,
or visual-spatial
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
3. Behavioral impairment: impairment in selfregulation as evidenced by mood or behavioral
regulation, attention deficit, or impulse control
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
E. Evidence of prenatal alcohol exposure
Confirmation of prenatal alcohol exposure
FINAL DIAGNOSIS:
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CASE #3 (Age 7yr-3mo boy)
Case #3 lives with his adoptive parents and their older biological daughter. He
was born full term. He was exposed to 12-18 cans of beer per week throughout
pregnancy. He came to live with his adoptive parents at 11 weeks old. His
developmental milestones were on time. He has been treated for strabismus
and has asthma. He is in a general education classroom. He has difficulties
with attention and anxiety, although does not take any medications and has not
received any prior mental health diagnosis or treatment.

Dysmorphology Exam: Height 126 cm, weight 23.3 kg, OFC 50 cm. Palpebral fissure length 2.7 cm. Lip and
philtrum shown above. No history of seizures.
Selected Test Results:
Intellectual Functioning (WISC-IV)
Full Scale IQ SS = 88, 21st percentile
Academic Achievement (ENI-2)
Reading precision: words with errors in reading aloud Sc = 12, 75th percentile
Arithmetic: written calculus Sc = 3, 1st percentile
Writing precision: percent of words with errors in written recall Sc = 9, 37th percentile
Verbal Memory (ENI-2)
Auditory-verbal memory Sc = 95, 37th percentile
Visual memory Sc = 93, 32nd percentile
Behavior Problems (SENA) (*high scores = worse performance)
Hyperactivity and impulsivity T = 91, >99th percentile
Attention difficulties T = 67, 96th percentile
Emotional regulation problems T = 70, 98th percentile
Index of problems in executive functioning = 76, >99th percentile
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Present/absent

Criteria

Notes

A. Characteristic pattern of minor facial anomalies, including two or more of the following:
1. Short palpebral fissures
2. Thin vermilion border of the upper lip
3. Smooth philtrum
B. Growth deficiency
Height and/or weight less than or equal to 10th
percentile
C. Deficient brain growth, structural brain anomalies, or recurrent nonfebrile seizures
1. Head circumference < 10th percentile
2. Structural brain anomalies
3. Recurrent nonfebrile seizures
D. Neurobehavioral impairment (more than 1.5 standard deviations below the mean)
1. Global impairment (IQ)
2. Cognitive impairment: impairment in executive
functioning, specific learning impairment, memory,
or visual-spatial
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
3. Behavioral impairment: impairment in selfregulation as evidenced by mood or behavioral
regulation, attention deficit, or impulse control
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
E. Evidence of prenatal alcohol exposure
Confirmation of prenatal alcohol exposure
FINAL DIAGNOSIS:
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CASE #4 (Age 6yr-1mo boy)
Case #4 is in foster care with his two siblings. His foster parent has limited
information about his birth and early growth and development. He was removed
from his mother’s care when he was 3 years old when he was found wandering
near the highway. His biological parents are known to have problems with drug and
alcohol use. It is unknown if he was exposed to alcohol or other substances during
pregnancy. Currently, he is in kindergarten.

Dysmorphology Exam: Weight 15.5 kg, height 106 cm, OFC 51 cm. Palpebral fissure length 2.3 cm. Lip and
philtrum shown above. No history of seizures.
Selected Test Results:
Intellectual Functioning (WISC-IV)
Full Scale IQ SS = 105, 63rd percentile
Memory (ENI-2)
Auditory-verbal memory SS = 95 , 37th percentile
Visual memory SS = 105, 63rd percentile
Visual stimuli recall memory SS = 95, 37th percentile
Executive Functioning (Child testing; ENI-2)
Verbal fluidity SS = 100, 50th percentile
Cognitive flexibility: percentage of perseverative responses Sc = 3, 1st percentile
Behavior Problems (SENA) (*high scores = worse performance)
Hyperactivity and impulsivity T = 79, >99th percentile
Attention difficulties T = 72, 99th percentile
Emotional regulation problems T = 69, 97th percentile
Index of problems in executive functioning = 72, 99th percentile
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Present/absent

Criteria

Notes

A. Characteristic pattern of minor facial anomalies, including two or more of the following:
1. Short palpebral fissures
2. Thin vermilion border of the upper lip
3. Smooth philtrum
B. Growth deficiency
Height and/or weight less than or equal to 10th
percentile
C. Deficient brain growth, structural brain anomalies, or recurrent nonfebrile seizures
1. Head circumference < 10th percentile
2. Structural brain anomalies
3. Recurrent nonfebrile seizures
D. Neurobehavioral impairment (more than 1.5 standard deviations below the mean)
1. Global impairment (IQ)
2. Cognitive impairment: impairment in executive
functioning, specific learning impairment, memory,
or visual-spatial
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
3. Behavioral impairment: impairment in selfregulation as evidenced by mood or behavioral
regulation, attention deficit, or impulse control
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
E. Evidence of prenatal alcohol exposure
Confirmation of prenatal alcohol exposure
FINAL DIAGNOSIS:
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CASE #5 (Age 8yr-9mo girl)
Case #5 lives with her aunt and uncle and their new baby. She has lived with
them since she was 18 months old. Information about pregnancy, labor, and
delivery with the child are largely unknown. The child’s mother has struggled
with severe mental illness, substance use, and homelessness. Prenatal
exposure to alcohol and cocaine are suspected, but unconfirmed. When she
came to live with her aunt she had limited language and her motor milestones
appeared delayed. The child is in a special education classroom at school and
receives a high level of services for behavior regulation support.

Dysmorphology Exam: Height 135.5 cm, weight 29 kg, OFC 52.5 cm. Palpebral fissure length 2.8 cm. Lip and
philtrum shown above. No known history of seizures.
Selected Test Results:
Intellectual Functioning (WISC-IV)
Verbal comprehension SS = 86, 18th percentile
Perceptual reasoning SS = 76, 5th percentile
Academic Achievement (ENI-2)
Reading precision: words with errors in reading aloud Sc = 8, 25th percentile
Arithmetic: written calculus Sc = 5, 5th percentile
Writing precision: percent of words with errors in written recall Sc = 8, 25th percentile
Memory (ENI-2)
Auditory-verbal memory SS = 75, 5th percentile
Auditory stimuli recall memory SS = 70, 2nd percentile
Visual memory SS = 80, 9th percentile
Visual stimuli recall memory SS = 75, 5th percentile
Spacial Skills (ENI-2) SS = 60, <1st percentile
Executive Functioning (Child testing)
WISC-IV Working memory SS = 70, 2nd percentile
ENI-2 Cognitive flexibility: percentage of perseverative responses Sc = 1, <1st percentile
ENI-2 Planning and organizing: correct designs Sc = 6, 9th percentile
Executive Functioning / Behavior Regulation (SENA *high scores = worse performance)
Index of problems in executive functioning T-score = 83, >99th percentile
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Present/absent

Criteria

Notes

A. Characteristic pattern of minor facial anomalies, including two or more of the following:
1. Short palpebral fissures
2. Thin vermilion border of the upper lip
3. Smooth philtrum
B. Growth deficiency
Height and/or weight less than or equal to 10th
percentile
C. Deficient brain growth, structural brain anomalies, or recurrent nonfebrile seizures
1. Head circumference < 10th percentile
2. Structural brain anomalies
3. Recurrent nonfebrile seizures
D. Neurobehavioral impairment (more than 1.5 standard deviations below the mean)
1. Global impairment (IQ)
2. Cognitive impairment: impairment in executive
functioning, specific learning impairment, memory,
or visual-spatial
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
3. Behavioral impairment: impairment in selfregulation as evidenced by mood or behavioral
regulation, attention deficit, or impulse control
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
E. Evidence of prenatal alcohol exposure
Confirmation of prenatal alcohol exposure
FINAL DIAGNOSIS:

38

CASE #6 (Age 3yrs-10 mo boy)
Case #6 was living with an extended relative and his biological older sister. He
lived with his biological parents until the age of 34 months and was removed
due to significant abuse and neglect. He was born full term via cesarean
section. He was in the NICU for three days and was released to his parents.
Reliable family members observed his mother drinking alcohol during her
pregnancy on multiple occasions and she was noted to have a DUI while
pregnant with the child. His developmental milestones were delayed. He
has been expelled from multiple daycares due to aggression. He has been
prescribed clonidine.

Dysmorphology Exam: Height 100.2 cm, weight 16.2 kg, OFC 49.5 cm. Palpebral fissure length 2.2 cm. Lip and
philtrum shown above. No history of seizures.
Selected Test Results:
Intellectual Functioning (WPPSI-III)
Full Scale IQ SS = 76, 5th percentile
Memory
Visual memory SS = 72, 3rd percentile
Behavior Problems (SENA) (*high scores = worse performance)
Hyperactivity and impulsivity T = 74, 99th percentile
Emotional regulation problems T = 71, 98th percentile
Attention difficulties T = 67, 96th percentile
Index of problems in executive functioning T = 83, >99th percentile
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Present/absent

Criteria

Notes

A. Characteristic pattern of minor facial anomalies, including two or more of the following:
1. Short palpebral fissures
2. Thin vermilion border of the upper lip
3. Smooth philtrum
B. Growth deficiency
Height and/or weight less than or equal to 10th
percentile
C. Deficient brain growth, structural brain anomalies, or recurrent nonfebrile seizures
1. Head circumference < 10th percentile
2. Structural brain anomalies
3. Recurrent nonfebrile seizures
D. Neurobehavioral impairment (more than 1.5 standard deviations below the mean)
1. Global impairment (IQ)
2. Cognitive impairment: impairment in executive
functioning, specific learning impairment, memory,
or visual-spatial
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
3. Behavioral impairment: impairment in selfregulation as evidenced by mood or behavioral
regulation, attention deficit, or impulse control
**for FAS/PFAS need impairment in one area in
this domain. For ARND need 2 areas of impairment
in this domain**
E. Evidence of prenatal alcohol exposure
Confirmation of prenatal alcohol exposure
FINAL DIAGNOSIS:
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Answer key
Final diagnosis:
Case 1: Alcohol-related neurodevelopmental disorder (ARND)
Case 2: Fetal alcohol syndrome (FAS)
Case 3: Alcohol-related neurodevelopmental disorder (ARND) with microcephaly
Case 4: Partial fetal alcohol syndrome (PFAS) without documented alcohol exposure
Case 5: No diagnosis of FASD
Case 6: Partial fetal alcohol syndrome (PFAS) with documented alcohol exposure
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Post-diagnosis of FASD: Ethical challenges and
suggested interventions
Ethical challenges
An assessment leading to the diagnosis of FASD has numerous benefits. Earlier diagnosis yields greater benefits
for affected children, which include a reduction in secondary disabilities such as substance abuse and learning
and cognitive disabilities leading to school failure, and improved life outcomes. Perhaps most importantly,
diagnosis provides a context for understanding a child’s behavior. When the environment surrounding a child
with an FASD opts to focus on the child’s strengths as a means for intervention, there is a greater likelihood of
that child achieving success as an adult. Diagnosis of FASD is further beneficial to the extent that it leads to a
reduction of future births of children with FASD.
However, to the extent that an FASD diagnosis presupposes prenatal alcohol exposure (PAE), it implies ethical
challenges. PAE implies that maternal behavior led to the child’s condition. Even in the absence of awareness of
the risks of PAE, a diagnosis associated with maternal behavior may lead to stigmatization, attribution of blame to
the mother, maternal guilt, altered family dynamics due to assignment of blame, and an impact on the maternalchild bonding process, especially when the diagnosis occurs during infancy.
Obtaining accurate information from women and families in order to produce an FASD diagnosis may be
challenging on its own. Cultural practices surrounding alcohol use may reduce stigma associated with PAE in
some parts of the world, resulting in greater willingness for women to disclose alcohol use, which in turn would
facilitate an earlier FASD diagnosis. At the same time, other communities that have been highly impacted by
FASD may respond more dramatically with laws designed to reduce PAE, which may negatively impact the
frequency of disclosure by women, particularly during pregnancy when interventions are most likely to be
effective.
Programs aimed at identifying children with FASD must be aware of these ethical challenges and consider
the context of the community as it will define the experiences of the family in dealing with this diagnosis. It is
imperative to seek paths that aim at maximizing the health and well-being of children and their mothers, on whom
children often depend. Indeed, keeping the best interest of the child in mind also calls for advancing the health
and well-being of the mother. Moreover, she may be in need of medical care herself (e.g., if she suffers from
alcohol addiction) or psychological support resulting from the awareness that she did something that caused harm
to her own child. Given that the majority of pregnancies are unplanned, so women are often unaware of their
pregnancy in the most vulnerable gestational period, and that relatively low amounts of alcohol suffice to cause
FASD, mothers’ need of psychological support may be more common than previously envisioned. In general, it
should be noted that greatest benefits for affected children result from advancing the health and well-being of
these children’s mothers.
Care should prevail to avoid imposing additional harms on affected children or their mothers, avoid interventions
or messages that could antagonize mothers and their children, and overall to advance the health and well-being
of both. Ethics guidance should be sought when FASD diagnosis poses further challenges.

Suggested interventions
The assignment of an FASD diagnosis to a patient, although essential, is only the initial step in the process of
providing support for these individuals. Further action is needed to maximize the potential benefits of diagnosis.
Any clinical diagnostic program must also establish protocols for referrals to appropriate specialists, and
individuals with the diagnosis need access to resources that support their long-term success.
When an FASD diagnosis is suspected, it is imperative to initially exclude any other possible causes such as a
genetic disorder that may require specific medical interventions. Often, if a patient has more findings than what would
be expected in FASD, chromosomal analysis in the form of a microarray is performed. This is the standard initial test
for any child with significant developmental delay or cognitive impairment when a definitive diagnosis is lacking.
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If no other genetic condition exists, and the FASD diagnosis is definitive, assessments of sensory input from the
environment necessary for development and the learning process are important. Annual ophthalmologic and
audiologic screening is recommended to identify any visual or hearing issues that may delay motor or language
development. Screening for some of the known congenital anomalies is also recommended, based on clinical
judgement. For example, a cardiac murmur heard on examination may necessitate an echocardiogram to further
evaluate for congenital heart disease that is known to have increased prevalence within the FASD population.
Abnormal spine examination (restriction in movement or scoliosis) may warrant spine X-rays to evaluate for
vertebral anomalies. Renal ultrasound is indicated in children with recurrent urinary tract infections to look for
renal anomalies associated with FASD. Early referral to habilitation and rehabilitation services such as speech
and language therapy or physical therapy can be important in optimizing function and social participation.
Some of the neurobehavioral issues associated with FASD can be treated pharmacologically, though there
are no medications that are approved specifically for FASD. For example, hyperactivity associated with FASD
may be treated with stimulant medication and mood disorders may be treated with selective serotonin uptake
inhibitors. However, a pharmacologic approach alone without appropriate in-school interventions often results in a
suboptimal treatment outcome.
For school-age children, educational support is vital and information regarding the ideal learning methodologies
for children with FASD should be provided to school educators. Understanding the unique neurobiology of
individuals with FASD can result in a more successful classroom experience and improved long-term outcomes
for these patients as adults. Patients and their caregivers must be given access to information so that they may
advocate for their needs to school officials and educators. Some school-based resources available free-of-charge
can be found at https://www.cdc.gov/ncbddd/fasd/educators.html
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The Regional Status Report on Alcohol and Health
in the Americas published in 2015 describes five key
recommendations based upon objectives described in
the global strategy report by the WHO. This document
serves to meet several of these objectives including
raising awareness, improving the knowledge base
about the magnitude of alcohol-related problems, and
improving monitoring systems and surveillance.
The detailed descriptions of methodology used in the
diagnosis of FASD along with the long-term outcome
and intervention information provided is ideal for
dissemination within countries of the Americas. The
experiences of the authors working in North, Central,
and South America provide a background of knowledge
and understanding of the extent of the problem and
the challenges faced by providers in these regions.
Much of the content was developed with this in mind
and includes examples of standard drinks, social and
community factors, and support services available
that would be relevant to the expected readership.
The training manual provides information regarding
the diagnostic process, the tools needed to perform
the necessary assessments, and case-based learning
modules to enhance learning and retention of critical
elements for an FASD diagnosis. There are also
components of the interventions provided to balance
the training regarding diagnosis with an avenue to move
forward that would be beneficial to patients.
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